University of Surrey

Test tubes in the lab Research in the ATI Dance Research

Items where Author is "Vidal, L"

Up a level
Export as [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Number of items: 11.

Article

Harrington, KJ, Karapanagiotou, EM, Roulstone, V, Twigger, KR, White, CL, Vidal, L, Beirne, D, Prestwich, R, Newbold, K, Ahmed, M, Thway, K, Nutting, CM, Coffey, M, Harris, D, Vile, RG, Pandha, HS, DeBono, JS and Melcher, AA (2010) Two-Stage Phase I Dose-Escalation Study of Intratumoral Reovirus Type 3 Dearing and Palliative Radiotherapy in Patients with Advanced Cancers CLINICAL CANCER RESEARCH, 16 (11). pp. 3067-3077.

Gospodinova, N, Ivanov, DA, Anokhin, DV, Mihai, I, Vidal, L, Brun, S, Romanova, J and Tadjer, A (2009) Unprecedented Route to Ordered Polyaniline: Direct Synthesis of Highly Crystalline Fibrillar Films with Strong π-π Stacking Alignment. Macromol Rapid Commun, 30 (1). pp. 29-33.

Vidal, L, Pandha, HS, Yap, TA, White, CL, Twigger, K, Vile, RG, Melcher, A, Coffey, M, Harrington, KJ and DeBono, JS (2008) A Phase I Study of Intravenous Oncolytic Reovirus Type 3 Dearing in Patients with Advanced Cancer CLINICAL CANCER RESEARCH, 14 (21). pp. 7127-7137.

White, CL, Twigger, KR, Vidal, L, De Bono, JS, Coffey, M, Heinemann, L, Morgan, R, Merrick, A, Errington, F, Vile, RG, Melcher, AA, Pandha, HS and Harrington, KJ (2008) Characterization of the adaptive and innate immune response to intravenous oncolytic reovirus (Dearing type 3) during a phase I clinical trial GENE THERAPY, 15 (12). pp. 911-920.

Errington, F, Steele, L, Prestwich, R, Harrington, KJ, Pandha, HS, Vidal, L, de Bono, J, Selby, P, Coffey, M, Vile, R and Melcher, A (2008) Reovirus activates human dendritic cells to promote innate antitumor immunity JOURNAL OF IMMUNOLOGY, 180 (9). pp. 6018-6026.

Twigger, K, Vidal, L, White, CL, De Bono, JS, Bhide, S, Coffey, M, Thompson, B, Vile, RG, Heinemann, L, Pandha, HS, Errington, F, Melcher, AA and Harrington, KJ (2008) Enhanced in vitro and in vivo cytotoxicity of combined reovirus and radiotherapy CLINICAL CANCER RESEARCH, 14 (3). pp. 912-923.

Harris, D, Vidal, L, Melcher, A, Newbold, K, Anthony, A, Karavasilis, V, Agarwal, R, White, C, Twigger, K, Coffey, M, Mettinger, K, Thompson, B, Pandha, H, De-Bono, J and Harrington, K (2007) A Phase I study to evaluate the feasibility, safety and biological effects of intratumoural administration of wild-type Reovirus (REOLYSIN (R)) in combination with radiation in patients with advanced malignancies. MOLECULAR CANCER THERAPEUTICS, 6 (12). 3458S-3458S.

Yap, TA, Vidal, L, Pandha, H, Spicer, J, Digue, L, Coffey, M, Thompson, B, Kaye, SB, Harrington, KJ and De-Bono, JS (2006) A phase I study of wild-type reovirus, which selectively replicates in cells expressing activated Ras, administered intravenously to patients with advanced cancer EJC SUPPLEMENTS, 4 (12). p. 108.

Conference or Workshop Item

Vidal, L, Pandha, H, Spicer, J, Harrington, KJ, Allen, S, Leader, D, Coffey, M, Thompson, B, Kaye, S and De-Bono, J (2006) A phase I study of reolysin given intravenously to patients with advanced malignancies. In: 42nd Annual Meeting of the American-Society-of-Clinical-Oncology, 2006-06-02 - 2006-06-06, Atlanta, GA.

Vidal, L, Twigger, K, White, C, Coffey, M, Thompson, B, De-Bono, J, Pandha, HS, Melcher, A, Kaye, S and Harrington, KJ (2005) Reovirus enhances radiation cytotoxicity in vitro and in vivo. In: AACR/NCI/EORTC International Conference on Molecular Targets and Cancer Therapeutics, 2005-11-14 - 2005-11-18, Philadelphia, PA.

Vidal, L, Pandha, H, Harrington, K, Fong, P, Shaw, H, Barrett, M, Leader, D, White, C, Twigger, K, Coffey, M, Thompson, B, Kaye, S and De-Bono, J (2005) A phase I study of a wild-type reovirus (Reolysin) given intravenously to patients with advanced malignancies. In: AACR/NCI/EORTC International Conference on Molecular Targets and Cancer Therapeutics, 2005-11-14 - 2005-11-18, Philadelphia, PA.

This list was generated on Sat Nov 25 11:27:25 2017 UTC.

Information about this web site

© The University of Surrey, Guildford, Surrey, GU2 7XH, United Kingdom.
+44 (0)1483 300800